Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy

Kennedy and Pottier discovered that photodynamic therapy (PDT) could be carried out using a procedure consisting of topical application of the porphyrin-precursor, 5-aminolevulinic acid (ALA) to the skin, followed after some time by illumination with various light parameters in the 1980s. Since then...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current dermatology reports 2016-09, Vol.5 (3), p.179-190
Hauptverfasser: Thunshelle, Connor, Yin, Rui, Chen, Qiquan, Hamblin, Michael R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 190
container_issue 3
container_start_page 179
container_title Current dermatology reports
container_volume 5
creator Thunshelle, Connor
Yin, Rui
Chen, Qiquan
Hamblin, Michael R.
description Kennedy and Pottier discovered that photodynamic therapy (PDT) could be carried out using a procedure consisting of topical application of the porphyrin-precursor, 5-aminolevulinic acid (ALA) to the skin, followed after some time by illumination with various light parameters in the 1980s. Since then, ALA-PDT has expanded enormously and now covers most aspects of dermatological disease. The purpose of this review is to discuss a range of ingenious strategies that investigators have devised for improving the overall outcome (higher efficiency and lower side effects) of ALA-PDT. The big advance of using ALA esters instead of the free acid to improve skin penetration was conceived in the 1990s. A variety of more recent innovative approaches can be divided into three broad groups: (a) those relying on improving delivery or penetration of ALA into the skin; (b) those relying on ways to increase the synthesis of protoporphyrin IX inside the skin; (c) those relying on modification of the illumination parameters. In the first group, we have improved delivery of ALA with penetration-enhancing chemicals, iontophoresis, intracutaneous injection, or fractionated laser. There is also a large group of nanotechnology-related approaches with ALA being delivered using liposomes/ethosomes, ALA dendrimers, niosomes, mesoporous silica nanoparticles, conjugated gold nanoparticles, polymer nanoparticles, fullerene nanoparticles, and carbon nanotubes. In the second group, we can find the use of cellular differentiating agents, the use of iron chelators, and the effect of increasing the temperature. In the third group, we find methods designed to reduce pain as well as improve efficiency including fractionated light, daylight PDT, and wearable light sources for ambulatory PDT. This active area of research is expected to continue to provide a range of intriguing possibilities.
doi_str_mv 10.1007/s13671-016-0154-5
format Article
fullrecord <record><control><sourceid>pubmed_sprin</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5287697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>28163981</sourcerecordid><originalsourceid>FETCH-LOGICAL-p206t-5a2da3f82c842622399a6e1f9441c21039f6f9845241a1df821f0227fa64dfa13</originalsourceid><addsrcrecordid>eNpVkN9KwzAYxYMobsw9gDfSF4jmf5sboQydwkQv5nWITbJltGlJ28He3oypzA_Cd-CcHJIfALcY3WOE8oceU5FjiLBIhzPIL8CUYEEgk5RenukJmPf9DqURKUz5NZiQIglZ4ClYLsYYbRiy0ux1qGyf-ZBxWDY-tLXdj7UPvsrKypvszRqvB2uyj207tOYQdJOs9dZG3R1uwJXTdW_nP3sGPp-f1osXuHpfvi7KFewIEgPkmhhNXUGqghFBCJVSC4udZAxXBCMqnXCyYJwwrLFJQewQIbnTghmnMZ2Bx1NvN3411lTp6VHXqou-0fGgWu3Vfyf4rdq0e8VJkQuZp4K784K_m79IUoCcAn2ywsZGtWvHGNKnFEbqiF6d0KtEUx3RK06_AdQydE0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy</title><source>SpringerNature Journals</source><creator>Thunshelle, Connor ; Yin, Rui ; Chen, Qiquan ; Hamblin, Michael R.</creator><creatorcontrib>Thunshelle, Connor ; Yin, Rui ; Chen, Qiquan ; Hamblin, Michael R.</creatorcontrib><description>Kennedy and Pottier discovered that photodynamic therapy (PDT) could be carried out using a procedure consisting of topical application of the porphyrin-precursor, 5-aminolevulinic acid (ALA) to the skin, followed after some time by illumination with various light parameters in the 1980s. Since then, ALA-PDT has expanded enormously and now covers most aspects of dermatological disease. The purpose of this review is to discuss a range of ingenious strategies that investigators have devised for improving the overall outcome (higher efficiency and lower side effects) of ALA-PDT. The big advance of using ALA esters instead of the free acid to improve skin penetration was conceived in the 1990s. A variety of more recent innovative approaches can be divided into three broad groups: (a) those relying on improving delivery or penetration of ALA into the skin; (b) those relying on ways to increase the synthesis of protoporphyrin IX inside the skin; (c) those relying on modification of the illumination parameters. In the first group, we have improved delivery of ALA with penetration-enhancing chemicals, iontophoresis, intracutaneous injection, or fractionated laser. There is also a large group of nanotechnology-related approaches with ALA being delivered using liposomes/ethosomes, ALA dendrimers, niosomes, mesoporous silica nanoparticles, conjugated gold nanoparticles, polymer nanoparticles, fullerene nanoparticles, and carbon nanotubes. In the second group, we can find the use of cellular differentiating agents, the use of iron chelators, and the effect of increasing the temperature. In the third group, we find methods designed to reduce pain as well as improve efficiency including fractionated light, daylight PDT, and wearable light sources for ambulatory PDT. This active area of research is expected to continue to provide a range of intriguing possibilities.</description><identifier>ISSN: 2162-4933</identifier><identifier>EISSN: 2162-4933</identifier><identifier>DOI: 10.1007/s13671-016-0154-5</identifier><identifier>PMID: 28163981</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Dermatology ; Laser Therapy (J Jagdeo ; Medicine ; Medicine &amp; Public Health ; Section Editor ; Topical Collection on Laser Therapy</subject><ispartof>Current dermatology reports, 2016-09, Vol.5 (3), p.179-190</ispartof><rights>Springer Science+Business Media New York 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-p206t-5a2da3f82c842622399a6e1f9441c21039f6f9845241a1df821f0227fa64dfa13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13671-016-0154-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s13671-016-0154-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28163981$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thunshelle, Connor</creatorcontrib><creatorcontrib>Yin, Rui</creatorcontrib><creatorcontrib>Chen, Qiquan</creatorcontrib><creatorcontrib>Hamblin, Michael R.</creatorcontrib><title>Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy</title><title>Current dermatology reports</title><addtitle>Curr Derm Rep</addtitle><addtitle>Curr Dermatol Rep</addtitle><description>Kennedy and Pottier discovered that photodynamic therapy (PDT) could be carried out using a procedure consisting of topical application of the porphyrin-precursor, 5-aminolevulinic acid (ALA) to the skin, followed after some time by illumination with various light parameters in the 1980s. Since then, ALA-PDT has expanded enormously and now covers most aspects of dermatological disease. The purpose of this review is to discuss a range of ingenious strategies that investigators have devised for improving the overall outcome (higher efficiency and lower side effects) of ALA-PDT. The big advance of using ALA esters instead of the free acid to improve skin penetration was conceived in the 1990s. A variety of more recent innovative approaches can be divided into three broad groups: (a) those relying on improving delivery or penetration of ALA into the skin; (b) those relying on ways to increase the synthesis of protoporphyrin IX inside the skin; (c) those relying on modification of the illumination parameters. In the first group, we have improved delivery of ALA with penetration-enhancing chemicals, iontophoresis, intracutaneous injection, or fractionated laser. There is also a large group of nanotechnology-related approaches with ALA being delivered using liposomes/ethosomes, ALA dendrimers, niosomes, mesoporous silica nanoparticles, conjugated gold nanoparticles, polymer nanoparticles, fullerene nanoparticles, and carbon nanotubes. In the second group, we can find the use of cellular differentiating agents, the use of iron chelators, and the effect of increasing the temperature. In the third group, we find methods designed to reduce pain as well as improve efficiency including fractionated light, daylight PDT, and wearable light sources for ambulatory PDT. This active area of research is expected to continue to provide a range of intriguing possibilities.</description><subject>Dermatology</subject><subject>Laser Therapy (J Jagdeo</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Section Editor</subject><subject>Topical Collection on Laser Therapy</subject><issn>2162-4933</issn><issn>2162-4933</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpVkN9KwzAYxYMobsw9gDfSF4jmf5sboQydwkQv5nWITbJltGlJ28He3oypzA_Cd-CcHJIfALcY3WOE8oceU5FjiLBIhzPIL8CUYEEgk5RenukJmPf9DqURKUz5NZiQIglZ4ClYLsYYbRiy0ux1qGyf-ZBxWDY-tLXdj7UPvsrKypvszRqvB2uyj207tOYQdJOs9dZG3R1uwJXTdW_nP3sGPp-f1osXuHpfvi7KFewIEgPkmhhNXUGqghFBCJVSC4udZAxXBCMqnXCyYJwwrLFJQewQIbnTghmnMZ2Bx1NvN3411lTp6VHXqou-0fGgWu3Vfyf4rdq0e8VJkQuZp4K784K_m79IUoCcAn2ywsZGtWvHGNKnFEbqiF6d0KtEUx3RK06_AdQydE0</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Thunshelle, Connor</creator><creator>Yin, Rui</creator><creator>Chen, Qiquan</creator><creator>Hamblin, Michael R.</creator><general>Springer US</general><scope>NPM</scope><scope>5PM</scope></search><sort><creationdate>20160901</creationdate><title>Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy</title><author>Thunshelle, Connor ; Yin, Rui ; Chen, Qiquan ; Hamblin, Michael R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p206t-5a2da3f82c842622399a6e1f9441c21039f6f9845241a1df821f0227fa64dfa13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Dermatology</topic><topic>Laser Therapy (J Jagdeo</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Section Editor</topic><topic>Topical Collection on Laser Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thunshelle, Connor</creatorcontrib><creatorcontrib>Yin, Rui</creatorcontrib><creatorcontrib>Chen, Qiquan</creatorcontrib><creatorcontrib>Hamblin, Michael R.</creatorcontrib><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current dermatology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thunshelle, Connor</au><au>Yin, Rui</au><au>Chen, Qiquan</au><au>Hamblin, Michael R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy</atitle><jtitle>Current dermatology reports</jtitle><stitle>Curr Derm Rep</stitle><addtitle>Curr Dermatol Rep</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>5</volume><issue>3</issue><spage>179</spage><epage>190</epage><pages>179-190</pages><issn>2162-4933</issn><eissn>2162-4933</eissn><abstract>Kennedy and Pottier discovered that photodynamic therapy (PDT) could be carried out using a procedure consisting of topical application of the porphyrin-precursor, 5-aminolevulinic acid (ALA) to the skin, followed after some time by illumination with various light parameters in the 1980s. Since then, ALA-PDT has expanded enormously and now covers most aspects of dermatological disease. The purpose of this review is to discuss a range of ingenious strategies that investigators have devised for improving the overall outcome (higher efficiency and lower side effects) of ALA-PDT. The big advance of using ALA esters instead of the free acid to improve skin penetration was conceived in the 1990s. A variety of more recent innovative approaches can be divided into three broad groups: (a) those relying on improving delivery or penetration of ALA into the skin; (b) those relying on ways to increase the synthesis of protoporphyrin IX inside the skin; (c) those relying on modification of the illumination parameters. In the first group, we have improved delivery of ALA with penetration-enhancing chemicals, iontophoresis, intracutaneous injection, or fractionated laser. There is also a large group of nanotechnology-related approaches with ALA being delivered using liposomes/ethosomes, ALA dendrimers, niosomes, mesoporous silica nanoparticles, conjugated gold nanoparticles, polymer nanoparticles, fullerene nanoparticles, and carbon nanotubes. In the second group, we can find the use of cellular differentiating agents, the use of iron chelators, and the effect of increasing the temperature. In the third group, we find methods designed to reduce pain as well as improve efficiency including fractionated light, daylight PDT, and wearable light sources for ambulatory PDT. This active area of research is expected to continue to provide a range of intriguing possibilities.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>28163981</pmid><doi>10.1007/s13671-016-0154-5</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2162-4933
ispartof Current dermatology reports, 2016-09, Vol.5 (3), p.179-190
issn 2162-4933
2162-4933
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5287697
source SpringerNature Journals
subjects Dermatology
Laser Therapy (J Jagdeo
Medicine
Medicine & Public Health
Section Editor
Topical Collection on Laser Therapy
title Current Advances in 5-Aminolevulinic Acid Mediated Photodynamic Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T23%3A39%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_sprin&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20Advances%20in%205-Aminolevulinic%20Acid%20Mediated%20Photodynamic%20Therapy&rft.jtitle=Current%20dermatology%20reports&rft.au=Thunshelle,%20Connor&rft.date=2016-09-01&rft.volume=5&rft.issue=3&rft.spage=179&rft.epage=190&rft.pages=179-190&rft.issn=2162-4933&rft.eissn=2162-4933&rft_id=info:doi/10.1007/s13671-016-0154-5&rft_dat=%3Cpubmed_sprin%3E28163981%3C/pubmed_sprin%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28163981&rfr_iscdi=true